Company: RACE
Filing Date: 2025-02-27
Form Type: 424B7
Source: 0001104659-25-017677
Chunk: 1

Company: Ferrari N.V.
Filing Date: 2025-02-27
Form: 424B7
Chunk 1
---
 (rounded down to the nearest whole number) equal to the lower of (i) 10% of the aggregate number of Common Shares sold in the Offerings and (ii) a number of Common Shares equal to an aggregate purchase price of €300,000,000 divided by the Offering Price (the “

#### Commitment
”), and at the other terms and subject to the conditions described in this prospectus supplement (the “

#### Share Buyback
”). The closing of the Share Buyback will occur as part of and concurrently with the closing of the Offerings. We cannot assure you that the Offerings or the Share Buyback will be consummated on the terms described herein or at all. See “Summary — Share Buyback from the Selling Securityholder”.

In the United States, Ferrari’s Common Shares are listed and traded on the New York Stock Exchange (“

#### NYSE
”) under the symbol “RACE”. Ferrari’s Common Shares are also listed and traded on Euronext Milan under the symbol “RACE”. The last reported sale price of Ferrari’s Common Shares on the NYSE on February 25, 2025 was $504.50 per Common Share. The last reported sale price of Ferrari’s Common Shares on Euronext Milan on February 25, 2025 was €477.40 per Common Share.

Investing in our Common Shares involves risk. See “Risk Factors” on page S-5of this prospectus supplement and “Risk Factors” in our Annual Report on Form 20-F for the year ended December 31, 2024 (the “Annual Report”), which is incorporated by reference herein, to read about factors you should consider before investing in the securities offered in this prospectus supplement and the accompanying prospectus.

Neither the U.S. Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.

This prospectus supplement does not constitute a prospectus within the meaning of the Prospectus Regulation or the UK Prospectus Regulation and has not been approved by the Dutch Authority for the Financial Markets, any other European Supervisory Authority or the UK Financial Conduct Authority.

TABLE OF CONTENTS

| ​                                                           | ​ | ​ | Per Common Share(3) |   |        |   |   |   |   |   |        |   | ​ | ​ | Total(3) |   |                  |